BMRN financial statements and SEC filings
BMRN annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $3.22B | $409.48M | $348.90M | 10-K |
| 2024-12-31 | $2.85B | $484.21M | $426.86M | 10-K |
| 2023-12-31 | $2.42B | $185.77M | $167.65M | 10-K |
| 2022-12-31 | $2.10B | $160.97M | $141.56M | 10-K |
| 2021-12-31 | $1.85B | -$82.34M | -$64.08M | 10-K |
| 2020-12-31 | $1.86B | -$43.44M | $854.03M | 10-K |
BMRN annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $7.59B | $1.51B | $6.09B | 10-Q |
| 2024-12-31 | $6.99B | $1.33B | $5.66B | 10-K |
| 2023-12-31 | $6.84B | $1.89B | $4.95B | 10-K |
| 2022-12-31 | $6.38B | $1.77B | $4.60B | 10-K |
| 2021-12-31 | $6.00B | $1.74B | $4.27B | 10-K |
| 2020-12-31 | $5.85B | $1.74B | $4.11B | 10-K |
BMRN annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $827.99M | -$103.04M | -$42.39M | 10-K |
| 2024-12-31 | $572.84M | -$85.42M | -$526.45M | 10-K |
| 2023-12-31 | $159.26M | -$96.69M | -$18.73M | 10-K |
| 2022-12-31 | $175.90M | -$120.96M | -$18.65M | 10-K |
| 2021-12-31 | $304.54M | -$95.58M | -$48.00K | 10-K |
| 2020-12-31 | $85.36M | -$114.31M | $181.12M | 10-K |